Literature DB >> 1952682

Role of anaerobic bacteria in perimandibular space infections.

J Horn, B S Bender, J G Bartlett.   

Abstract

This review includes 44 patients with perimandibular space infections admitted to Johns Hopkins Hospital during a 5-year period. The most frequent spaces involved were the submandibular, peritonsillar, and parapharyngeal spaces. As expected, 1) peritonsillar abscesses were invariably associated with pharyngitis, 2) submandibular and buccal space infections generally represented complications of dental infections, and 3) parapharyngeal space infections were associated with both portals of entry. Most patients were treated with drainage procedures, and all received antimicrobial agents, the most common being penicillin. Serious complications included potential airway obstruction requiring tracheostomy in six patients with Fusobacterium bacteremia and two patients with septic emboli to the lung. All patients survived, and most had a relatively brief hospitalization with no sequelae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952682     DOI: 10.1177/00034894911000s910

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  3 in total

1.  Polysaccharide A-Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes.

Authors:  M Hanief Sofi; Benjamin M Johnson; Radhika R Gudi; Amy Jolly; Marie-Claude Gaudreau; Chenthamarakshan Vasu
Journal:  Diabetes       Date:  2019-07-16       Impact factor: 9.461

2.  Mediastinitis following deep neck infections : A therapeutic challenge.

Authors:  N K Panda; S B Mann; S C Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2000-10

3.  Acute sore throat and Fusobacterium necrophorum in primary healthcare: a systematic review and meta-analysis.

Authors:  Stefan Malmberg; Susanna Petrén; Ronny Gunnarsson; Katarina Hedin; Pär-Daniel Sundvall
Journal:  BMJ Open       Date:  2021-06-04       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.